These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35838586)

  • 21. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
    Weber C; Büchner SM; Schnierle BS
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003684. PubMed ID: 25905779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography.
    Fox JM; Roy V; Gunn BM; Bolton GR; Fremont DH; Alter G; Diamond MS; Boesch AW
    Front Immunol; 2023; 14():1153108. PubMed ID: 37251375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice.
    Zhao Z; Deng Y; Niu P; Song J; Wang W; Du Y; Huang B; Wang W; Zhang L; Zhao P; Tan W
    Front Immunol; 2021; 12():655743. PubMed ID: 33868299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.
    Kam YW; Lee WW; Simarmata D; Le Grand R; Tolou H; Merits A; Roques P; Ng LF
    PLoS One; 2014; 9(4):e95647. PubMed ID: 24755730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroreactivity to Chikungunya and West Nile Viruses in Rwandan Blood Donors.
    Seruyange E; Ljungberg K; Muvunyi CM; Gahutu JB; Katare S; Nyamusore J; Gwon YD; Evander M; Norder H; Liljeström P; Bergström T
    Vector Borne Zoonotic Dis; 2019 Oct; 19(10):731-740. PubMed ID: 31246538
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.
    Kim YC; López-Camacho C; Garcia-Larragoiti N; Cano-Mendez A; Hernandez-Flores KG; Domínguez-Alemán CA; Mar MA; Vivanco-Cid H; Viveros-Sandoval ME; Reyes-Sandoval A
    Viruses; 2019 May; 11(5):. PubMed ID: 31052472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.
    Fumagalli MJ; de Souza WM; Romeiro MF; de Souza Costa MC; Slhessarenko RD; Figueiredo LTM
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.
    Kam YW; Lum FM; Teo TH; Lee WW; Simarmata D; Harjanto S; Chua CL; Chan YF; Wee JK; Chow A; Lin RT; Leo YS; Le Grand R; Sam IC; Tong JC; Roques P; Wiesmüller KH; Rénia L; Rötzschke O; Ng LF
    EMBO Mol Med; 2012 Apr; 4(4):330-43. PubMed ID: 22389221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis.
    Carlsen TG; Hjelholt A; Jurik AG; Schiøttz-Christensen B; Zejden A; Christiansen G; Deleuran B; Birkelund S
    Arthritis Res Ther; 2013; 15(3):R61. PubMed ID: 23705835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA).
    Skov M; Pressler T; Jensen HE; Høiby N; Koch C
    Thorax; 1999 Jan; 54(1):44-50. PubMed ID: 10343631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum immunoglobulin G subclass responses in different phases of hepatitis E virus infection.
    Deshmukh TM; Shah RR; Gurav YK; Arankalle VA
    J Med Virol; 2013 May; 85(5):828-32. PubMed ID: 23508908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.
    García-Arriaza J; Cepeda V; Hallengärd D; Sorzano CÓ; Kümmerer BM; Liljeström P; Esteban M
    J Virol; 2014 Mar; 88(6):3527-47. PubMed ID: 24403588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
    Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
    Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
    J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High yield expression and purification of Chikungunya virus E2 recombinant protein and its evaluation for serodiagnosis.
    Verma A; Chandele A; Nayak K; Kaja MK; Arulandu A; Lodha R; Ray P
    J Virol Methods; 2016 Sep; 235():73-79. PubMed ID: 27180040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
    Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
    Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of chikungunya virus infection among febrile patients in northwest Ethiopia.
    Ferede G; Tiruneh M; Abate E; Wondimeneh Y; Gadisa E; Howe R; Aseffa A; Tessema B
    Int J Infect Dis; 2021 Mar; 104():183-188. PubMed ID: 33373719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of Chikungunya fever in an Indian population by an indirect enzyme-linked immunosorbent assay protocol based on an antigen detection assay: a prospective cohort study.
    Kashyap RS; Morey SH; Ramteke SS; Chandak NH; Parida M; Deshpande PS; Purohit HJ; Taori GM; Daginawala HF
    Clin Vaccine Immunol; 2010 Feb; 17(2):291-7. PubMed ID: 20007365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.